

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Clinical management of herpes simplex virus... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1726/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1726" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Clinical management of herpes simplex virus infections: past, present, and future" />
    
            <meta name="og:title" content="F1000Research Article: Clinical management of herpes simplex virus infections: past, present, and future.">
            <meta name="og:description" content="Read the latest article version by Richard Whitley, Joel Baines, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="17644">
            <meta name="article-id" content="16157">
            <meta name="dc.title" content="Clinical management of herpes simplex virus infections: past, present, and future">
            <meta name="dc.description" content="Infection with herpes simplex virus (HSV) types 1 and 2 is ubiquitous in the human population. Most commonly, virus replication is limited to the epithelia and establishes latency in enervating sensory neurons, reactivating periodically to produce localized recurrent lesions. However, these viruses can also cause severe disease such as recurrent keratitis leading potentially to blindness, as well as encephalitis, and systemic disease in neonates and immunocompromised patients. Although antiviral therapy has allowed continual and substantial improvement in the management of both primary and recurrent infections, resistance to currently available drugs and long-term toxicity pose a current and future threat that should be addressed through the development of new antiviral compounds directed against new targets. The development of several promising HSV vaccines has been terminated recently because of modest or controversial therapeutic effects in humans. Nevertheless, several exciting vaccine candidates remain in the pipeline and are effective in animal models; these must also be tested in humans for sufficient therapeutic effects to warrant continued development. Approaches using compounds that modulate the chromatin state of the viral genome to suppress infection and reactivation or induce enhanced antiviral immunity have potential. In addition, technologies such as CRISPR/Cas9 have the potential to edit latent viral DNA in sensory neurons, potentially curing the neuron and patient of latent infection. It is hoped that development on all three fronts&mdash;antivirals, vaccines, and gene editing&mdash;will lead to substantially less HSV morbidity in the future.">
            <meta name="dc.subject" content="Herpes simplex virus, antiviral compounds, Herpes encephalitis, CRISPR/Cas9, vaccine, HSV-1, HSV-2">
            <meta name="dc.creator" content="Whitley, Richard">
            <meta name="dc.creator" content="Baines, Joel">
            <meta name="dc.date" content="2018/10/31">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.16157.1">
            <meta name="dc.source" content="F1000Research 2018 7:1726">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Herpes simplex virus">
            <meta name="prism.keyword" content="antiviral compounds">
            <meta name="prism.keyword" content="Herpes encephalitis">
            <meta name="prism.keyword" content="CRISPR/Cas9">
            <meta name="prism.keyword" content="vaccine">
            <meta name="prism.keyword" content="HSV-1">
            <meta name="prism.keyword" content="HSV-2">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/10/31">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1726">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.16157.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1726">
            <meta name="citation_title" content="Clinical management of herpes simplex virus infections: past, present, and future">
            <meta name="citation_abstract" content="Infection with herpes simplex virus (HSV) types 1 and 2 is ubiquitous in the human population. Most commonly, virus replication is limited to the epithelia and establishes latency in enervating sensory neurons, reactivating periodically to produce localized recurrent lesions. However, these viruses can also cause severe disease such as recurrent keratitis leading potentially to blindness, as well as encephalitis, and systemic disease in neonates and immunocompromised patients. Although antiviral therapy has allowed continual and substantial improvement in the management of both primary and recurrent infections, resistance to currently available drugs and long-term toxicity pose a current and future threat that should be addressed through the development of new antiviral compounds directed against new targets. The development of several promising HSV vaccines has been terminated recently because of modest or controversial therapeutic effects in humans. Nevertheless, several exciting vaccine candidates remain in the pipeline and are effective in animal models; these must also be tested in humans for sufficient therapeutic effects to warrant continued development. Approaches using compounds that modulate the chromatin state of the viral genome to suppress infection and reactivation or induce enhanced antiviral immunity have potential. In addition, technologies such as CRISPR/Cas9 have the potential to edit latent viral DNA in sensory neurons, potentially curing the neuron and patient of latent infection. It is hoped that development on all three fronts&mdash;antivirals, vaccines, and gene editing&mdash;will lead to substantially less HSV morbidity in the future.">
            <meta name="citation_description" content="Infection with herpes simplex virus (HSV) types 1 and 2 is ubiquitous in the human population. Most commonly, virus replication is limited to the epithelia and establishes latency in enervating sensory neurons, reactivating periodically to produce localized recurrent lesions. However, these viruses can also cause severe disease such as recurrent keratitis leading potentially to blindness, as well as encephalitis, and systemic disease in neonates and immunocompromised patients. Although antiviral therapy has allowed continual and substantial improvement in the management of both primary and recurrent infections, resistance to currently available drugs and long-term toxicity pose a current and future threat that should be addressed through the development of new antiviral compounds directed against new targets. The development of several promising HSV vaccines has been terminated recently because of modest or controversial therapeutic effects in humans. Nevertheless, several exciting vaccine candidates remain in the pipeline and are effective in animal models; these must also be tested in humans for sufficient therapeutic effects to warrant continued development. Approaches using compounds that modulate the chromatin state of the viral genome to suppress infection and reactivation or induce enhanced antiviral immunity have potential. In addition, technologies such as CRISPR/Cas9 have the potential to edit latent viral DNA in sensory neurons, potentially curing the neuron and patient of latent infection. It is hoped that development on all three fronts&mdash;antivirals, vaccines, and gene editing&mdash;will lead to substantially less HSV morbidity in the future.">
            <meta name="citation_keywords" content="Herpes simplex virus, antiviral compounds, Herpes encephalitis, CRISPR/Cas9, vaccine, HSV-1, HSV-2">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Richard Whitley">
            <meta name="citation_author_institution" content="Department of Pediatrics, Microbiology, and Medicine, University of Alabama at Birmingham Children&rsquo;s Hospital, Birmingham, AL, 35233, USA">
            <meta name="citation_author" content="Joel Baines">
            <meta name="citation_author_institution" content="Department of Pathobiology, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, 70803, USA">
            <meta name="citation_publication_date" content="2018/10/31">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1726">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.16157.1">
            <meta name="citation_firstpage" content="1726">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1726/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1726.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=17644 /> <input type=hidden id=articleId name=articleId value=16157 /> <input type=hidden id=xmlUrl value="/articles/7-1726/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1726-v1.xml"> <input type=hidden id=article_uuid value=9116c98d-399f-494a-b82a-d304c78d140f /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Clinical management of herpes simplex virus infections: past, present, and future"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.16157.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.16157.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1726"
  },
  "headline": "Clinical management of herpes simplex virus infections: past, present, and future",
  "datePublished": "2018-10-31T15:53:58",
  "dateModified": "2018-10-31T15:53:58",
  "author": [
    {
      "@type": "Person",
      "name": "Richard Whitley"
    },    {
      "@type": "Person",
      "name": "Joel Baines"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Infection with herpes simplex virus (HSV) types 1 and 2 is ubiquitous in the human population. Most commonly, virus replication is limited to the epithelia and establishes latency in enervating sensory neurons, reactivating periodically to produce localized recurrent lesions. However, these viruses can also cause severe disease such as recurrent keratitis leading potentially to blindness, as well as encephalitis, and systemic disease in neonates and immunocompromised patients. Although antiviral therapy has allowed continual and substantial improvement in the management of both primary and recurrent infections, resistance to currently available drugs and long-term toxicity pose a current and future threat that should be addressed through the development of new antiviral compounds directed against new targets. The development of several promising HSV vaccines has been terminated recently because of modest or controversial therapeutic effects in humans. Nevertheless, several exciting vaccine candidates remain in the pipeline and are effective in animal models; these must also be tested in humans for sufficient therapeutic effects to warrant continued development. Approaches using compounds that modulate the chromatin state of the viral genome to suppress infection and reactivation or induce enhanced antiviral immunity have potential. In addition, technologies such as CRISPR/Cas9 have the potential to edit latent viral DNA in sensory neurons, potentially curing the neuron and patient of latent infection. It is hoped that development on all three fronts&mdash;antivirals, vaccines, and gene editing&mdash;will lead to substantially less HSV morbidity in the future."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1726",
            "name": "Clinical management of herpes simplex virus infections: past, present,..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Clinical management of herpes simplex virus infections: past, present,... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=17644 data-id=16157 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16157.1" data-recommended="" data-doi="10.12688/f1000research.16157.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1726/v1/pdf?article_uuid=9116c98d-399f-494a-b82a-d304c78d140f" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-16157-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-16157-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-16157-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Whitley R and Baines J. Clinical management of herpes simplex virus infections: past, present, and future [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1726 (<a class=new-orange href="https://doi.org/10.12688/f1000research.16157.1" target=_blank>https://doi.org/10.12688/f1000research.16157.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-16157-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=16157 id=track-article-signin-16157 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16157?target=/articles/7-1726">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17644 /> <input name=articleId type=hidden value=16157 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Clinical management of herpes simplex virus infections: past, present, and future</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Richard Whitley<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:Jbaines@lsu.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Joel Baines</span></a><a href="https://orcid.org/0000-0002-6397-2830" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6397-2830</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Richard Whitley<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:Jbaines@lsu.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Joel Baines</span></a><a href="http://orcid.org/0000-0002-6397-2830" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6397-2830</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 31 Oct 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.16157.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Pediatrics, Microbiology, and Medicine, University of Alabama at Birmingham Children&rsquo;s Hospital, Birmingham, AL, 35233, USA<br/> <sup>2</sup> Department of Pathobiology, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, 70803, USA<br/> <p> <div class=margin-bottom> Richard Whitley <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Joel Baines <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=40679-39758></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=40677-39757></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Infection with herpes simplex virus (HSV) types 1 and 2 is ubiquitous in the human population. Most commonly, virus replication is limited to the epithelia and establishes latency in enervating sensory neurons, reactivating periodically to produce localized recurrent lesions. However, these viruses can also cause severe disease such as recurrent keratitis leading potentially to blindness, as well as encephalitis, and systemic disease in neonates and immunocompromised patients. Although antiviral therapy has allowed continual and substantial improvement in the management of both primary and recurrent infections, resistance to currently available drugs and long-term toxicity pose a current and future threat that should be addressed through the development of new antiviral compounds directed against new targets. The development of several promising HSV vaccines has been terminated recently because of modest or controversial therapeutic effects in humans. Nevertheless, several exciting vaccine candidates remain in the pipeline and are effective in animal models; these must also be tested in humans for sufficient therapeutic effects to warrant continued development. Approaches using compounds that modulate the chromatin state of the viral genome to suppress infection and reactivation or induce enhanced antiviral immunity have potential. In addition, technologies such as CRISPR/Cas9 have the potential to edit latent viral DNA in sensory neurons, potentially curing the neuron and patient of latent infection. It is hoped that development on all three fronts—antivirals, vaccines, and gene editing—will lead to substantially less HSV morbidity in the future. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Herpes simplex virus, antiviral compounds, Herpes encephalitis, CRISPR/Cas9, vaccine, HSV-1, HSV-2 </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Joel Baines (<a href="mailto:Jbaines@lsu.edu">Jbaines@lsu.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Joel Baines </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This piece was supported in part by the National Institutes of Health – Public Health Service. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Whitley R and Baines J. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Whitley R and Baines J. Clinical management of herpes simplex virus infections: past, present, and future [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1726 (<a href="https://doi.org/10.12688/f1000research.16157.1" target=_blank>https://doi.org/10.12688/f1000research.16157.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 31 Oct 2018, <b>7</b>(F1000 Faculty Rev):1726 (<a href="https://doi.org/10.12688/f1000research.16157.1" target=_blank>https://doi.org/10.12688/f1000research.16157.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 31 Oct 2018, <b>7</b>(F1000 Faculty Rev):1726 (<a href="https://doi.org/10.12688/f1000research.16157.1" target=_blank>https://doi.org/10.12688/f1000research.16157.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d8966e161>Introduction</h2><p class="" id=d8966e164>Herpes simplex virus (HSV) infections have been reported since ancient Greek times<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>. During the 20th century, the clinical manifestations of these infections were broadly reported in the medical literature. In particular, life-threatening disease, such as neonatal HSV infections and herpes simplex encephalitis, appeared in the literature for the first time in the 1930s. Several fundamental early observations provide the basis for today’s understanding of HSV. First, once infected, an individual can have recurrences in spite of both humoral and cell-mediated immune responses (leading to the recognition that the virus establishes latency and may recur upon various provocative stimuli to produce disease). Second, the differentiation between HSV-1 and HSV-2 was clearly recognized. Historically, HSV-1 was associated with infection above the belt, namely the mouth and eye, whereas HSV-2 was attributed to infections below the belt, specifically genital herpes. However, in contemporary times, there is significant overlap between the sites of HSV infection with an ever-increasing proportion of genital herpes caused by HSV-1. In the US, over 50% of adults are seropositive for HSV-1 and about 15% of those who are sexually active are infected by HSV-2<sup><a href="#ref-3">3</a>–<a href="#ref-6">6</a></sup>. Infections caused by these viruses are, for the most part, benign. Third, person-to-person transmission, particularly in boarding houses and among sexual partners, was reported.</p><p class="" id=d8966e181>Only toward the end of the 20th century was there a ballooning of knowledge regarding the epidemiology, pathogenesis, virulence, and fundamentals of latent infection. The application of two important tools allowed major insights into pathogenesis, namely type-specific serology and polymerase chain reaction (PCR). Furthermore, antiviral therapy, particularly acyclovir, became routinely available, marking the beginning of the management of HSV disease. During the 21st century, important new observations relevant to the pathogenesis have been identified. Furthermore, the identification of novel antiviral approaches as well as the application of contemporary technology, such as CRISPR/Cas9, should prove of value moving forward. This review will summarize advances which have been realized within the past several years and outline promising future approaches to prevent and decrease HSV-mediated disease.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8966e187>Neonatal herpes simplex virus infection</h2><p class="" id=d8966e190>Neonatal HSV infections are among the most devastating of all those caused by this virus<sup><a href="#ref-7">7</a></sup>. Recent analyses of large-population databases provide insight into the incidence of disease in the US. Whereas the incidence is low, namely 5.24 cases per 10,000 live-births in the US, the potential morbidity and mortality from this infection remain high; adjusted mortality is about 4% in spite of antiviral therapy<sup><a href="#ref-6">6</a>,<a href="#ref-8">8</a></sup>. For reasons that are unclear, the incidence is much lower in other countries of the world.</p><p class="" id=d8966e204>There are three forms of neonatal HSV infection: disease localized to the skin, eye, and mouth (SEM); encephalitis; and disseminated disease<sup><a href="#ref-1">1</a></sup>. The development and licensure of acyclovir for the treatment of life-threatening HSV disease have had a major impact on clinical outcomes. About 45% of babies will have SEM disease for which there is no attributable mortality; however, some of these babies can develop intellectual impairment for reasons noted below.</p><p class="" id=d8966e211>About 35% of affected babies will have central nervous system (CNS) disease and the remaining will have disseminated multi-organ disease. Mortality is the highest with disseminated disease, about 40%, whereas mortality with CNS disease is only 5%<sup><a href="#ref-7">7</a>,<a href="#ref-9">9</a></sup>.</p><p class="" id=d8966e221>Several recent advances in our understanding of neonatal HSV disease are particularly noteworthy. First, utilization of PCR has allowed the diagnosis of CNS disease without either brain biopsy or culture of the cerebrospinal fluid (CSF)<sup><a href="#ref-10">10</a></sup>. More importantly, of those babies who appear to have disease localized to the SEM, about 10% have detectable HSV DNA within the CSF at the time of clinical presentation. The cytology of their CSF was entirely normal, implying that they had asymptomatic infection of the CNS. Indeed, this group of children ultimately developed neurologic impairment. Thus, it has become standard of care to assess the CSF for the presence of HSV DNA at presentation. If HSV DNA is detected, these babies should be managed with a longer course of acyclovir (21 days) than if disease were simply limited to the SEM (14 days)<sup><a href="#ref-11">11</a></sup>.</p><p class="" id=d8966e233>Second, PCR analyses that were performed at the beginning and conclusion of treatment identified several important factors. For babies with CNS infection, CSF PCR remained positive for HSV DNA after a full course of antiviral therapy, namely 14 days, in 40% of newborns. This finding is of significant concern and implies that treatment should be extended, as is now the case, to 21 days. Equally importantly, those babies who had HSV-2 infections of the CNS were more likely to remain PCR-positive in the CSF than those who were infected by HSV-1. This finding mirrored the morbidity such that those babies with HSV-2 infections had a much more severe neurologic outcome than those babies with HSV-1. Lastly, PCR positivity at the conclusion of antiviral therapy predicted long-term outcome, including mortality.</p><p class="" id=d8966e236>With babies remaining PCR-positive at the completion of intravenous antiviral therapy, an important question was, “Do these children have low-grade persistent infection of the central nervous system?” In the absence of a direct way to determine such a finding, long-term suppressive therapy with oral acyclovir was evaluated in a placebo-controlled study<sup><a href="#ref-12">12</a></sup>. The data from this study indicate that those who received oral acyclovir for six months following intravenous drug had a significantly better neurologic outcome, as determined by the Bayley Developmental Scale III, than those who received the counterpart placebo. This is not an insignificant finding, as it implies that HSV has the ability to replicate in the brain at low levels and may, as a consequence, result in long-term neurologic damage. With the management approach of six months of suppressive therapy, the number of children who return to normal function can be increased significantly. Suppressive therapy has recently become the management of choice as recommended by the American Academy of Pediatrics Red Book committee<sup><a href="#ref-11">11</a></sup>.</p><p class="" id=d8966e247>As no vaccine is immediately on the horizon (see ‘Vaccines’ section below), alternative methods of preventing neonatal herpes need to be developed. Rapid PCR assays deployed in the delivery suite to determine whether a woman is excreting virus at the time of delivery are being evaluated with the opportunity to administer antiviral therapy to the baby delivered through an infected birth canal. These studies remain experimental and should be completed by 2020. In the meantime, the American Academy of Pediatrics has recommended that babies delivered through an infected birth canal be managed in a definitive prospective fashion. Namely, if the mother has an established recurrent infection, surface swabs are obtained for PCR analysis and for cultures. If the PCR is positive, CSF would need to be examined and intravenous acyclovir therapy instituted. On the other hand, if the mother has a confirmed primary infection, acyclovir for a minimum of 14 days is recommended, following cutaneous swab evaluation for accretion of virus and CSF assessment. Hopefully, this approach will decrease the incidence of neonatal herpes simplex infection.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8966e253>Herpes simplex encephalitis</h2><p class="" id=d8966e256>Although antiviral therapy was proven to decrease mortality from herpes simplex encephalitis with the institution of vidarabine therapy in the late 1970s, it was not until much later (1986) that acyclovir was proven to be beneficial in the treatment of biopsy-proven herpes simplex encephalitis<sup><a href="#ref-13">13</a></sup>. Significant knowledge has increased our understanding of the diagnosis, treatment, and management of herpes simplex encephalitis. First, the overall incidence of herpes simplex encephalitis has not changed significantly since the early 1980s (1 in 100,000 to 150,000 individuals)<sup><a href="#ref-14">14</a></sup>. In the absence of a formal reporting system, it is unlikely that greater precision in incidence will be achieved. Second, and more importantly, the application of PCR for the detection of HSV DNA in the CSF provided the gold standard for the diagnosis of herpes simplex encephalitis, replacing brain biopsy as the legitimate diagnostic<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>. Importantly, the sensitivity and specificity of PCR were established in comparison with biopsy in biopsy-proven disease versus those with other diseases. However, although PCR is the gold standard for diagnosis, it should be recognized that there is significant variability in test performance between one laboratory and another. Appropriate controls must be employed in order to obtain a reliable and reproducible result. Second, because of the high morbidity and mortality of herpes simplex encephalitis (mortality of about 20% six months after disease onset), the early institution of intravenous acyclovir therapy has been adopted across the US. Usually but not uniformly, empiric treatment is provided to patients who present with findings compatible with herpes simplex encephalitis<sup><a href="#ref-17">17</a></sup>. Specifically, those patients with fever, altered mentation, and CSF abnormalities with or without focal neurologic findings are started on acyclovir while PCR studies on the CSF are being performed. It is unclear whether the early institution of such antiviral therapy has had a major impact on the morbidity and mortality of the disease.</p><p class="" id=d8966e278>Since the original descriptions of morbidity with the first clinical trials of acyclovir, an understanding of outcome has been developed through reviews and summaries of patients that total over 200 individuals with proven herpes simplex encephalitis<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. Overall, acute 30-day mortality has been reported to be as low as 5 to 10% but increases to about 20% by day 180. Of the remaining population, 20% have severe neurologic sequelae, 20% have moderate neurologic sequelae, and 40% are left minimally impaired.</p><p class="" id=d8966e288>Recently, a placebo-controlled study tested the hypothesis that long-term oral valacyclovir administration would improve neurologic outcome for those with proven disease, as oral acyclovir did for neonatal HSV infection<sup><a href="#ref-20">20</a></sup>. However, when administered at a dose of 2 grams three times a day for three months, valacyclovir did not improve outcome as compared with placebo. Nevertheless, the study provided, for the first time, data that defined the long-term functional status (~two years) after the onset of acute disease. It also demonstrated that significant and dramatic neurologic improvement occurred regardless of receiving drug or placebo during this two-year period, but especially in the first six months, using very sophisticated neurologic evaluations. Specifically, a Mattis Dementia Rating Scale and a Mini-Mental State Examination were applied to 79 patients with confirmed herpes simplex encephalitis. At baseline (day 30), 36% were assessed as having moderate/severe impairment with both tests. Conversely, 64% were assessed as having mild impairment. At 6-, 12-, and 24-month assessments, the percentage of patients with moderate/severe impairment decreased to 16, 12, and 10, respectively, for both tests. Thus, 90% of patients were functional with no or mild impairment.</p><p class="" id=d8966e295>As noted above, the long-term administration of valacyclovir to patients with herpes simplex encephalitis was instituted with the presumption that chronic replication could occur in the CNS as presumably is the case in babies with neonatal herpes caused by HSV-2. However, herpes simplex encephalitis in older children and adults is routinely caused by HSV-1. Thus, the implication is that HSV-1 does not have the propensity to replicate chronically in the brain as occurs with HSV-2.</p><p class="" id=d8966e299>Much remains to be improved in the management of this disease. Drugs that cross the blood–brain barrier as well as combination therapies should be considered for future studies of herpes simplex encephalitis. Perhaps only then will mortality and morbidity be further reduced.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8966e305>Resistance</h2><p class="" id=d8966e308>With the advent of antiviral therapy for herpesvirus infections, the concern for resistance has become one of paramount importance. In the early 1980s, acyclovir was the first of the nucleoside analogs having an acceptable safety profile that was licensed for the treatment of HSV infections. Medication could be applied topically, administered intravenously, or taken orally. Since then, prototypic drugs for the treatment of these infections include famciclovir (the prodrug of penciclovir) and valacyclovir (the prodrug of acyclovir). All of these drugs must be phosphorylated in order to be active. Upon entry of the drug into infected cells, the first phosphorylation step is performed by the virus-encoded thymidine kinase. Two additional phosphorylation steps are then mediated by host cellular kinases. Ultimately, acyclovir triphosphate is a substrate for viral DNA polymerase and becomes a DNA polymerase chain terminator because of the lack of a 3′-hydroxyl group. Penciclovir triphosphate, however, allows limited chain elongation because of a 3′-hydroxyl group on its acyclic side chain. These medications have become the mainstay for the management of both HSV and varicella zoster virus infections in the immune-competent as well as the immune-compromised host.</p><p class="" id=d8966e311>Short-term administration of any of these medications is very rarely associated with the development of resistance. However, long-term administration has been associated with the development of resistance, particularly in the immunocompromised host. In large part, this is due to prolonged high levels of replication in the immunocompromised host that are consequential to a compromised immune response.</p><p class="" id=d8966e314>For example, screening surveys of immunocompetent patients would indicate that the prevalence of HSV resistance is less than 1%<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup>. However, in the immunocompromised host, the prevalence varies between about 4 and 10%. In HIV-infected patients, particularly those with a low CD4 count, resistance occurs in about 7% of patients. In solid organ and hematopoietic stem cell transplant recipients, the prevalence of resistance is consistently higher, exceeding 10%<sup><a href="#ref-23">23</a></sup>. In such cases, persistent and severe disease have been reported. Thus, as will be noted below, alternative strategies for managing these patients are mandatory<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup>.</p><p class="" id=d8966e335>As noted above, these nucleoside analogs require intracellular phosphorylation by herpes simplex thymidine kinase. Thus, mutations in the <i>UL23</i> gene that encodes viral thymidine kinase can arise and confer resistance. Three different phenotypes have been reported: thymidine kinase–negative mutants, which lack enzymatic activity; low thymidine kinase–producing mutants that express very low levels of this enzyme; and thymidine kinase–altered isolates, which are substrate-specific mutants. The majority of mutants encountered in humans are those that are thymidine kinase–deficient. Most cases of acyclovir resistance result from mutations of the <i>UL23</i> gene that result in frame shifts in the coding sequence. DNA polymerase mutations are encountered significantly less frequently than thymidine kinase mutants but can confer drug resistance as well<sup><a href="#ref-26">26</a></sup>.</p><p class="" id=d8966e349>When resistance is suspected on the basis of observations of progressive lesions that develop during appropriate antiviral therapy, either genotypic or phenotypic testing should be performed. In some cases, the resistance can be overcome by administering intravenous acyclovir at higher doses. However, this is of only limited utility. As a consequence, alternative therapeutics may be required. At present, only two such therapeutics are approved by the US Food and Drug Administration: foscarnet and cidofovir. Foscarnet is a pyrophosphate analog that inhibits viral DNA polymerase by mimicking the structure of pyrophosphate. As such, it does not require phosphorylation for activation. Rarely, foscarnet-resistant isolates have been obtained from individuals with AIDS. The alternative drug currently available is cidofovir. Cidofovir is an acyclic nucleoside phosphonate. The drug does not require virus-encoded thymidine kinase to be activated. Mutations conferring resistance to cidofovir have been mapped to certain domains of the DNA polymerase. Both foscarnet and cidofovir are associated with toxicity and therefore must be used with caution<sup><a href="#ref-24">24</a></sup>. Thus, it is obvious that alternative therapeutic approaches are required.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8966e359>Further unmet medical needs</h2><div class=section><a name=d8966e362 class=n-a></a><h3 class=section-title>Antivirals</h3><p class="" id=d8966e367>In spite of the advances in the management of HSV infections with nucleoside analogs, improved therapeutics with alternative mechanisms of actions and enhanced bioavailability are required. Many patients have recurrent corneal disease caused by HSV, and reviews on management have been published recently<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>. Viral replication and the potentially sight-threatening inflammation and scarring that accompanies it are often kept in check by long-term acyclovir therapy. Long-term administration, however, can lead to a substantial level of drug resistance in viruses isolated from the affected eye<sup><a href="#ref-29">29</a></sup>. New antiviral drugs alone or in combination with acyclovir should be developed to help control such infections and to diminish the possibility of resistance.</p><p class="" id=d8966e381>Two medications are being evaluated for the management of systemic HSV infections: pritelivir and brincidofovir. Pritelivir is a helicase primase inhibitor that plays an essential role in HSV DNA replication<sup><a href="#ref-30">30</a>–<a href="#ref-32">32</a></sup>. Pritelivir is extremely active in cell culture and has been shown in two clinical trials to have significant activity against genital HSV infections. To date, therapy has been limited to the short-term treatment of genital herpetic infections as opposed to long-term suppressive therapy. Further long-term toxicity studies are in progress to determine acceptability of long-term suppressive administration. Pritelivir is currently being evaluated for effectiveness against acyclovir-resistant HSV infections in the immunocompromised host.</p><p class="" id=d8966e391>Brincidofovir, a lipophilic derivative of cidofovir, has a mechanism of action similar to that of cidofovir but does not have the associated nephrotoxicity. The medication was originally developed for the management of human cytomegalovirus infections in hematopoietic stem cell transplant recipients<sup><a href="#ref-33">33</a></sup>. However, gastrointestinal tract toxicity was noted and therefore the drug is no longer being evaluated for this indication. It is unclear whether this medication will ultimately be available for administration to humans under such circumstances. Nevertheless, the medication does have activity against acyclic nucleoside–resistant viruses.</p><p class="" id=d8966e398>The development of new therapeutics for HSV infections is clearly impeded by the lack of interest on the part of the pharmaceutical industry. Because of the high safety of drugs such as acyclovir, valacyclovir, and famciclovir, the market need for additional drugs is significantly reduced from the perspective of most pharmaceutical companies.</p><p class="" id=d8966e402>Many lessons have been learned from the management of HIV infection and the treatment of hepatitis C virus infections. The most salient of these lessons is the synergistic activity of combination therapies. Such an approach needs to be developed in the management of life-threatening HSV infections, particularly of the newborn and of the CNS. Experimental data in animal models unequivocally show synergy when acyclovir and brincidofovir are combined in the treatment of murine models of neonatal HSV infections; synergy has also been noted upon combination of pritelivir and acyclovir in the management of murine encephalitis models. It is hoped that, within a reasonable period of time, these medications can be brought into human studies despite the potential toxicity of the former and inability to administer the latter in the long term<sup><a href="#ref-34">34</a></sup>.</p></div><div class=section><a name=d8966e410 class=n-a></a><h3 class=section-title>Vaccines</h3><p class="" id=d8966e415>The goal of HSV therapeutic vaccines would be to reduce the severity of symptoms, accelerate healing of lesions, and reduce virus shedding and infectivity to other individuals. Preventative vaccines might also preclude symptoms of disease induced by wild-type virus and reduce or prevent virus shedding. For HSV, vaccination would be particularly useful in women to reduce transmission to newborns during birth and in the general population to reduce recurrent ocular disease and to reduce transmission to sexual partners. An example of a successful preventative herpes virus vaccine is the varicella zoster vaccine, which has been shown to reduce shedding and severity of varicella (chicken pox) in children<sup><a href="#ref-35">35</a></sup>.</p><p class="" id=d8966e422>Despite many attempts, neither a therapeutic nor preventive vaccine exists for HSV-1 or -2. Although all vaccines that have been investigated thus far stimulate virus-specific immune responses and reduce mortality and virus shedding in animals, they have ultimately yielded disappointing results in human trials, leading to termination of vaccine development. The most recent of these are as follows.</p><p class="" id=d8966e425>In June 2018, a VICal vaccine trial “did not meet proper end point” in diminishment of HSV-2–induced lesions and the VICal HSV-2 program was terminated. This vaccine comprises plasmids encoding HSV-2 viral proteins glycoprotein D, VP11/12 encoded by UL46, and UL47-encoded VP13/14 formulated with cationic lipid–based adjuvant Vaxfectin<sup>®</sup><sup><a href="#ref-36">36</a></sup>. Although the vaccine was well tolerated during the human trial and was previously shown to be effective against recurrent lesions in animal models, the magnitude of the effect in the test population—HSV-2–infected individuals who reactivated relatively frequently (four to nine times per year)—did not warrant further investment.</p><p class="" id=d8966e434>Second, the company Genocea (Cambridge, MA, USA) will reportedly no longer singularly develop its GEN-003 vaccine after results from a partially conducted phase III trial revealed only limited clinical efficacy. This vaccine comprises HSV-2 gD lacking its transmembrane domain and a truncated form of infected cell polypeptide 4 (ICP4) formulated in a Matrix M-2 adjuvant. Vaccination with GEN-003 reduced shedding and severity of lesions in animal models and reduced HSV-2 shedding in human patients<sup><a href="#ref-37">37</a></sup>.</p><p class="" id=d8966e442>Third, an attenuated HSV-2 vaccine lacking sequences encoding the viral transcriptional transactivator ICP0 was tested in animals and humans<sup><a href="#ref-38">38</a></sup>. Although the vaccine reduced mortality and viral shedding in mice<sup><a href="#ref-39">39</a></sup>, controversial trials in humans were conducted in the absence of full institutional review board permission and are being investigated. Anecdotes from vaccinees claiming both efficacy and severe side effects have been reported.</p><p class="" id=d8966e453>Despite these setbacks, several new vaccine candidates continue to show promising results in animal models:</p><div class=list><a name=d8966e456 class=n-a></a><ul style="list-style-type: none"><li><p id=d8966e463><span class=label>1. </span> An HSV-2 vaccine lacking two genes (<i>UL5</i> and <i>UL29</i>) essential for DNA replication has been shown to induce specific immune responses and significantly reduce mortality, viral shedding, and duration of lesions in virus-challenged animals<sup><a href="#ref-40">40</a></sup>. This vaccine is unable to produce infectious virus, thereby limiting spread from cell to cell. It poses a potential advantage over subunit vaccines because it allows presentation of viral antigens in the context of major histocompatibility complex (MHC) molecules in infected cells, thus boosting T-cell responses.</p></li><li><p id=d8966e482><span class=label>2. </span> The vaccine VC2 contains deletions of sequences within gK and <i>UL20</i> that render the virus unable to enter axons. However, VC2 replicates well in epithelial cells allowing its propagation in epithelial cell lines<sup><a href="#ref-41">41</a>–<a href="#ref-43">43</a></sup>. Precluding viral entrance into axons is a potentially important feature as it should prevent establishment of latent infection in the bodies of sensory neurons. VC2 has been shown to induce protection of mice from lethal challenge and to induce neutralizing antibodies in rhesus macaques.</p></li><li><p id=d8966e501><span class=label>3. </span> A vaccine comprising the HSV-2 glycoproteins C, D, and E has been shown to induce neutralizing antibodies against gD and antibodies that reduce the immune evasion activities of gC and gE<sup><a href="#ref-44">44</a></sup>. Vaccination of macaques and guinea pigs reduced severity of lesions upon challenge.</p></li></ul></div><p class="" id=d8966e510>Whether any of these promising leads will ultimately generate an effective HSV-1 or HSV-2 vaccine will require demonstration of substantial reduction of lesions in human clinical trials. In the past, this has been a difficult hurdle to overcome.</p></div><div class=section><a name=d8966e514 class=n-a></a><h3 class=section-title>Gene editing</h3><p class="" id=d8966e519>Latent infection with HSV is established in sensory ganglia when genomic viral DNA is transported to the nuclei of sensory neurons. The viral DNA is maintained throughout the life of the neuron in a partially heterochromatic state. Replication initiates from some of these genomes periodically, and infectious virus is delivered down the axon to the original site of epithelial infection, causing recurrent disease. Specific cleavage or an induced lethal mutation of latent viral DNA would potentially preclude recurrent infections, thus curing patients of HSV infection for the first time. Such an advance would revolutionize treatment. Although it is still in the early stages, use of endonuclease systems such as CRISPR/Cas9 to target herpesvirus genomes in infected cells is ongoing<sup><a href="#ref-45">45</a></sup>. The delivery of these systems to edit viral genomes within neurons <i>in vivo</i> will pose a challenge, but use of adeno-associated viruses or other neurotropic vectors represents a promising approach<sup><a href="#ref-26">26</a></sup>.</p></div><div class=section><a name=d8966e534 class=n-a></a><h3 class=section-title>Repression of cellular targets</h3><p class="" id=d8966e539>Intriguing studies suggest that antiviral targets might include cellular genes. Repurposing of drugs with known activities therefore has the potential to broadly enrich the anti-HSV pharmacopeia. For example, inhibition of the AKT signaling pathway can limit HSV replication in the eye<sup><a href="#ref-46">46</a></sup>. As another example, because reactivation from latent infection requires that the viral genome convert from a heterochromatic to a euchromatic state, drugs that preclude this conversion have the potential to prevent recurrent disease<sup><a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d8966e558>Abbreviations</h2><p class="" id=d8966e561>CNS, central nervous system; CSF, cerebrospinal fluid; HSV-1, herpes simplex virus type 1; HSV-2, herpes simplex virus type 2; PCR, polymerase chain reaction; SEM, disease localized to the skin, eye, and mouth</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d8966e1 class=n-a></a><h2 class=main-title id=d9138>Grant information</h2><p>This piece was supported in part by the National Institutes of Health – Public Health Service.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d8966e568 class=n-a></a><h2 class=main-title id=d8966e570>Acknowledgments</h2><p class="" id=d8966e573>The authors would like to acknowledge present and past members of their laboratories and Dunia Ritchey for reading and editing the manuscript.</p></div><div class=back-section><a name=d8966e577 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d9292>References</h2><div class="section ref-list"><a name=d8966e577 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d8966e584 class=n-a></a>Roizman B, Knipe D, Whitley R: Herpes Simplex Viruses. In Knipe D, Howley P (ed), <i>Fields Virology,</i> LWW, Philadelphia. 2013; <b>2</b>: 1823–1897.</span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d8966e599 class=n-a></a>Roizman B, Whitley RJ: The nine ages of herpes simplex virus. <i>Herpes.</i> 2001; <b>8</b>(1): 23–7. <a target=xrefwindow id=d8966e607 href="http://www.ncbi.nlm.nih.gov/pubmed/11867013">PubMed Abstract </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733323699"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e616 class=n-a></a>McQuillan G, Kruszon-Moran D, Flagg EW, <i> et al.</i>: Prevalence of Herpes Simplex Virus Type 1 and Type 2 in Persons Aged 14-49: United States, 2015-2016. <i>NCHS Data Brief.</i> 2018; (304): 1–8. <a target=xrefwindow id=d8966e624 href="http://www.ncbi.nlm.nih.gov/pubmed/29442994">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733323699">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d8966e637 class=n-a></a>Xu F, Sternberg MR, Kottiri BJ, <i> et al.</i>: Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. <i>JAMA.</i> 2006; <b>296</b>(8): 964–73. <a target=xrefwindow id=d8966e648 href="http://www.ncbi.nlm.nih.gov/pubmed/16926356">PubMed Abstract </a> | <a target=xrefwindow id=d8966e651 href="https://doi.org/10.1001/jama.296.8.964">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d8966e660 class=n-a></a>Roberts CM, Pfister JR, Spear SJ: Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. <i>Sex Transm Dis.</i> 2003; <b>30</b>(10): 797–800. <a target=xrefwindow id=d8966e668 href="http://www.ncbi.nlm.nih.gov/pubmed/14520181">PubMed Abstract </a> | <a target=xrefwindow id=d8966e671 href="https://doi.org/10.1097/01.OLQ.0000092387.58746.C7">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727273507"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e681 class=n-a></a>Looker KJ, Magaret AS, May MT, <i> et al.</i>: First estimates of the global and regional incidence of neonatal herpes infection. <i>Lancet Glob Health.</i> 2017; <b>5</b>(3): e300–e309. <a target=xrefwindow id=d8966e692 href="http://www.ncbi.nlm.nih.gov/pubmed/28153513">PubMed Abstract </a> | <a target=xrefwindow id=d8966e695 href="https://doi.org/10.1016/S2214-109X(16)30362-X">Publisher Full Text </a> | <a target=xrefwindow id=d8966e699 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5837040">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727273507">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732679045"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e712 class=n-a></a>Kabani N, Kimberlin DW: Neonatal Herpes Simplex Virus Infection. <i>Neoreviews.</i> 2018; <b>19</b>(2): e89–e96. <a target=xrefwindow id=d8966e720 href="https://doi.org/10.1542/neo.19-2-e89">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732679045">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d8966e733 class=n-a></a>Shah S, Hall M, Schondelmeyer A, <i> et al.</i>: Trends in Neonatal Herpes Simplex Virus Infection in the United States, 2000-2012. p. In (ed).</span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d8966e745 class=n-a></a>Kimberlin DW, Lin CY, Jacobs RF, <i> et al.</i>: Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. <i>Pediatrics.</i> 2001; <b>108</b>(2): 230–8. <a target=xrefwindow id=d8966e756 href="http://www.ncbi.nlm.nih.gov/pubmed/11483782">PubMed Abstract </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d8966e765 class=n-a></a>Kimberlin DW, Lakeman FD, Arvin AM, <i> et al.</i>: Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. <i>J Infect Dis.</i> 1996; <b>174</b>(6): 1162–7. <a target=xrefwindow id=d8966e776 href="http://www.ncbi.nlm.nih.gov/pubmed/8940204">PubMed Abstract </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d8966e785 class=n-a></a>Anonymous: Redbook, 31st ed. American Academy of Pediatrics. 2018. </span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13356041"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e795 class=n-a></a>Kimberlin DW, Whitley RJ, Wan W, <i> et al.</i>: Oral acyclovir suppression and neurodevelopment after neonatal herpes. <i>N Engl J Med.</i> 2011; <b>365</b>(14): 1284–92. <a target=xrefwindow id=d8966e806 href="http://www.ncbi.nlm.nih.gov/pubmed/21991950">PubMed Abstract </a> | <a target=xrefwindow id=d8966e809 href="https://doi.org/10.1056/NEJMoa1003509">Publisher Full Text </a> | <a target=xrefwindow id=d8966e813 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3250992">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13356041">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d8966e826 class=n-a></a>Whitley RJ, Alford CA, Hirsch MS, <i> et al.</i>: Vidarabine versus acyclovir therapy in herpes simplex encephalitis. <i>N Engl J Med.</i> 1986; <b>314</b>(3): 144–9. <a target=xrefwindow id=d8966e837 href="http://www.ncbi.nlm.nih.gov/pubmed/3001520">PubMed Abstract </a> | <a target=xrefwindow id=d8966e840 href="https://doi.org/10.1056/NEJM198601163140303">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d8966e849 class=n-a></a>Whitley R: Herpes Simplex Virus. In Scheld W, Whitley R, Marra C (ed), <i>Infections of the Central Nervous System,</i> 3rd ed. LWW, Philadelphia. 2004; 123–144. <a target=xrefwindow id=d8966e854 href="https://books.google.co.in/books?hl=en&amp;lr=&amp;id=jjvFj6aQeMgC&amp;oi=fnd&amp;pg=PA123&amp;dq=Herpes+Simplex+Virus&amp;ots=gUQBgEdkl9&amp;sig=IITHm47R8a8m__FoV_3d-1mC8pQ#v=onepage&amp;q=Herpes%20Simplex%20Virus&amp;f=false">Reference Source</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d8966e863 class=n-a></a>Rowley AH, Whitley RJ, Lakeman FD, <i> et al.</i>: Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. <i>Lancet.</i> 1990; <b>335</b>(8687): 440–1. <a target=xrefwindow id=d8966e874 href="http://www.ncbi.nlm.nih.gov/pubmed/1968171">PubMed Abstract </a> | <a target=xrefwindow id=d8966e877 href="https://doi.org/10.1016/0140-6736(90)90667-T">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d8966e886 class=n-a></a>Lakeman F, Whitley RJ: Diagnosis of herpes simplex encephalitis: results of PCR on CSF from biopsy positive and biopsy negative patients. p. In (ed). </span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d8966e895 class=n-a></a>Whitley R: Herpes Simplex Virus Infections. In Singhi P, Griffin D, Newton C (ed), <i>Infections of the CNS in Children.</i> Mac Keith Press. 2014.</span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d8966e908 class=n-a></a>Jouan Y, Grammatico-Guillon L, Espitalier F, <i> et al.</i>: Long-term outcome of severe herpes simplex encephalitis: a population-based observational study. <i>Crit Care.</i> 2015; <b>19</b>(1): 345. <a target=xrefwindow id=d8966e919 href="http://www.ncbi.nlm.nih.gov/pubmed/26387515">PubMed Abstract </a> | <a target=xrefwindow id=d8966e922 href="https://doi.org/10.1186/s13054-015-1046-y">Publisher Full Text </a> | <a target=xrefwindow id=d8966e926 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4576407">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d8966e935 class=n-a></a>Raschilas F, Wolff M, Delatour F, <i> et al.</i>: Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. <i>Clin Infect Dis.</i> 2002; <b>35</b>(3): 254–60. <a target=xrefwindow id=d8966e946 href="http://www.ncbi.nlm.nih.gov/pubmed/12115090">PubMed Abstract </a> | <a target=xrefwindow id=d8966e949 href="https://doi.org/10.1086/341405">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d8966e958 class=n-a></a>Gnann JW Jr, Sköldenberg B, Hart J, <i> et al.</i>: Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy. <i>Clin Infect Dis.</i> 2015; <b>61</b>(5): 683–91. <a target=xrefwindow id=d8966e969 href="http://www.ncbi.nlm.nih.gov/pubmed/25956891">PubMed Abstract </a> | <a target=xrefwindow id=d8966e972 href="https://doi.org/10.1093/cid/civ369">Publisher Full Text </a> | <a target=xrefwindow id=d8966e976 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4542890">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d8966e985 class=n-a></a>Christophers J, Clayton J, Craske J, <i> et al.</i>: Survey of resistance of herpes simplex virus to acyclovir in northwest England. <i>Antimicrob Agents Chemother.</i> 1998; <b>42</b>(4): 868–72. <a target=xrefwindow id=d8966e996 href="http://www.ncbi.nlm.nih.gov/pubmed/9559798">PubMed Abstract </a> | <a target=xrefwindow id=d8966e999 href="https://doi.org/10.1128/AAC.42.4.868">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1003 href="http://www.ncbi.nlm.nih.gov/pmc/articles/105557">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d8966e1012 class=n-a></a>Collins P, Larder BA, Oliver NM, <i> et al.</i>: Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. <i>J Gen Virol.</i> 1989; <b>70</b>(Pt 2): 375–82. <a target=xrefwindow id=d8966e1023 href="http://www.ncbi.nlm.nih.gov/pubmed/2543743">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1026 href="https://doi.org/10.1099/0022-1317-70-2-375">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d8966e1035 class=n-a></a>Bacon TH, Levin MJ, Leary JJ, <i> et al.</i>: Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. <i>Clin Microbiol Rev.</i> 2003; <b>16</b>(1): 114–28. <a target=xrefwindow id=d8966e1046 href="http://www.ncbi.nlm.nih.gov/pubmed/12525428">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1049 href="https://doi.org/10.1128/CMR.16.1.114-128.2003">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1053 href="http://www.ncbi.nlm.nih.gov/pmc/articles/145299">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d8966e1063 class=n-a></a>Piret J, Boivin G: Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. <i>Antimicrob Agents Chemother.</i> 2011; <b>55</b>(2): 459–72. <a target=xrefwindow id=d8966e1071 href="http://www.ncbi.nlm.nih.gov/pubmed/21078929">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1074 href="https://doi.org/10.1128/AAC.00615-10">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1077 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3028810">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d8966e1086 class=n-a></a>Jiang YC, Feng H, Lin YC, <i> et al.</i>: New strategies against drug resistance to herpes simplex virus. <i>Int J Oral Sci.</i> 2016; <b>8</b>(1): 1–6. <a target=xrefwindow id=d8966e1097 href="http://www.ncbi.nlm.nih.gov/pubmed/27025259">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1100 href="https://doi.org/10.1038/ijos.2016.3">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1104 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4822185">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d8966e1113 class=n-a></a>Bourdenx M, Dutheil N, Bezard E, <i> et al.</i>: Systemic gene delivery to the central nervous system using Adeno-associated virus. <i>Front Mol Neurosci.</i> 2014; <b>7</b>: 50. <a target=xrefwindow id=d8966e1124 href="http://www.ncbi.nlm.nih.gov/pubmed/24917785">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1127 href="https://doi.org/10.3389/fnmol.2014.00050">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1131 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4040820">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733115022"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e1140 class=n-a></a>Roozbahani M, Hammersmith KM: Management of herpes simplex virus epithelial keratitis. <i>Curr Opin Ophthalmol.</i> 2018; <b>29</b>(4): 360–4. <a target=xrefwindow id=d8966e1148 href="http://www.ncbi.nlm.nih.gov/pubmed/29697435">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1151 href="https://doi.org/10.1097/ICU.0000000000000483">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733115022">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733322520"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e1164 class=n-a></a>Kalezic T, Mazen M, Kuklinski E, <i> et al.</i>: Herpetic eye disease study: lessons learned. <i>Curr Opin Ophthalmol.</i> 2018; <b>29</b>(4): 340–6. <a target=xrefwindow id=d8966e1175 href="http://www.ncbi.nlm.nih.gov/pubmed/29846207">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1178 href="https://doi.org/10.1097/ICU.0000000000000482">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733322520">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d8966e1191 class=n-a></a>van Velzen M, van de Vijver DA, van Loenen FB, <i> et al.</i>: Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. <i>J Infect Dis.</i> 2013; <b>208</b>(9): 1359–65. <a target=xrefwindow id=d8966e1202 href="http://www.ncbi.nlm.nih.gov/pubmed/23901090">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1205 href="https://doi.org/10.1093/infdis/jit350">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727127362"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e1215 class=n-a></a>Wald A, Timmler B, Magaret A, <i> et al.</i>: Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial. <i>JAMA.</i> 2016; <b>316</b>(23): 2495–503. <a target=xrefwindow id=d8966e1226 href="http://www.ncbi.nlm.nih.gov/pubmed/27997653">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1229 href="https://doi.org/10.1001/jama.2016.18189">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727127362">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d8966e1242 class=n-a></a>Wald A, Corey L, Timmler B, <i> et al.</i>: Helicase-primase inhibitor pritelivir for HSV-2 infection. <i>N Engl J Med.</i> 2014; <b>370</b>(3): 201–10. <a target=xrefwindow id=d8966e1253 href="http://www.ncbi.nlm.nih.gov/pubmed/24428466">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1256 href="https://doi.org/10.1056/NEJMoa1301150">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d8966e1265 class=n-a></a>Whitley RJ, Prichard M: A novel potential therapy for HSV. <i>N Engl J Med.</i> 2014; <b>370</b>(3): 273–4. <a target=xrefwindow id=d8966e1273 href="http://www.ncbi.nlm.nih.gov/pubmed/24428473">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1276 href="https://doi.org/10.1056/NEJMe1313982">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d8966e1285 class=n-a></a>Gagelmann N, Ljungman P, Styczynski J, <i> et al.</i>: Comparative Efficacy and Safety of Different Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis. <i>Biol Blood Marrow Transplant.</i> 2018; pii: S1083-8791(18)30269-6. <a target=xrefwindow id=d8966e1293 href="http://www.ncbi.nlm.nih.gov/pubmed/29777868">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1296 href="https://doi.org/10.1016/j.bbmt.2018.05.017">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d8966e1305 class=n-a></a>De SK, Hart JC, Breuer J: Herpes simplex virus and varicella zoster virus: recent advances in therapy. <i>Curr Opin Infect Dis.</i> 2015; <b>28</b>(6): 589–95. <a target=xrefwindow id=d8966e1313 href="http://www.ncbi.nlm.nih.gov/pubmed/26524331">PubMed Abstract </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733513763"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e1322 class=n-a></a>Rafferty E, McDonald W, Qian W, <i> et al.</i>: Evaluation of the effect of chickenpox vaccination on shingles epidemiology using agent-based modeling. <i>PeerJ.</i> 2018; <b>6</b>: e5012. <a target=xrefwindow id=d8966e1333 href="http://www.ncbi.nlm.nih.gov/pubmed/29942688">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1336 href="https://doi.org/10.7717/peerj.5012">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1340 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6015493">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733513763">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d8966e1354 class=n-a></a>Veselenak RL, Shlapobersky M, Pyles RB, <i> et al.</i>: A Vaxfectin<sup>®</sup>-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes. <i>Vaccine.</i> 2012; <b>30</b>(49): 7046–51. <a target=xrefwindow id=d8966e1368 href="http://www.ncbi.nlm.nih.gov/pubmed/23041125">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1372 href="https://doi.org/10.1016/j.vaccine.2012.09.057">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1375 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3807597">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d8966e1384 class=n-a></a>Skoberne M, Cardin R, Lee A, <i> et al.</i>: An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs. <i>J Virol.</i> 2013; <b>87</b>(7): 3930–42. <a target=xrefwindow id=d8966e1395 href="http://www.ncbi.nlm.nih.gov/pubmed/23365421">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1398 href="https://doi.org/10.1128/JVI.02745-12">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1402 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3624190">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d8966e1411 class=n-a></a>Halford WP, Püschel R, Rakowski B: Herpes simplex virus 2 <i>ICP0</i> mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine. <i>PLoS One.</i> 2010; <b>5</b>(8): e12251. <a target=xrefwindow id=d8966e1422 href="http://www.ncbi.nlm.nih.gov/pubmed/20808928">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1425 href="https://doi.org/10.1371/journal.pone.0012251">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1429 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2923193">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d8966e1438 class=n-a></a>Halford WP, Püschel R, Gershburg E, <i> et al.</i>: A live-attenuated HSV-2 <i>ICP0</i> virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine. <i>PLoS One.</i> 2011; <b>6</b>(3): e17748. <a target=xrefwindow id=d8966e1452 href="http://www.ncbi.nlm.nih.gov/pubmed/21412438">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1456 href="https://doi.org/10.1371/journal.pone.0017748">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1459 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3055896">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d8966e1468 class=n-a></a>Hoshino Y, Pesnicak L, Dowdell KC, <i> et al.</i>: Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 <i>dl5</i>-29 and <i>dl5</i>-29-41L in mice and guinea pigs. <i>Vaccine.</i> 2008; <b>26</b>(32): 4034–40. <a target=xrefwindow id=d8966e1486 href="http://www.ncbi.nlm.nih.gov/pubmed/18565628">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1489 href="https://doi.org/10.1016/j.vaccine.2008.05.022">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1492 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2564964">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d8966e1501 class=n-a></a>Jambunathan N, Charles AS, Subramanian R, <i> et al.</i>: Deletion of a Predicted β-Sheet Domain within the Amino Terminus of Herpes Simplex Virus Glycoprotein K Conserved among Alphaherpesviruses Prevents Virus Entry into Neuronal Axons. <i>J Virol.</i> 2015; <b>90</b>(5): 2230–9. <a target=xrefwindow id=d8966e1512 href="http://www.ncbi.nlm.nih.gov/pubmed/26656706">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1515 href="https://doi.org/10.1128/JVI.02468-15">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1519 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4810717">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d8966e1529 class=n-a></a>Stanfield BA, Stahl J, Chouljenko VN, <i> et al.</i>: A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains. <i>PLoS One.</i> 2014; <b>9</b>(10): e109890. <a target=xrefwindow id=d8966e1540 href="http://www.ncbi.nlm.nih.gov/pubmed/25350288">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1543 href="https://doi.org/10.1371/journal.pone.0109890">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1547 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4211657">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727145911"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e1556 class=n-a></a>Stanfield BA, Pahar B, Chouljenko VN, <i> et al.</i>: Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies. <i>Vaccine.</i> 2017; <b>35</b>(4): 536–43. <a target=xrefwindow id=d8966e1567 href="http://www.ncbi.nlm.nih.gov/pubmed/28017425">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1570 href="https://doi.org/10.1016/j.vaccine.2016.12.018">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727145911">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727222065"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e1583 class=n-a></a>Awasthi S, Hook LM, Shaw CE, <i> et al.</i>: An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs. <i>PLoS Pathog.</i> 2017; <b>13</b>(1): e1006141. <a target=xrefwindow id=d8966e1594 href="http://www.ncbi.nlm.nih.gov/pubmed/28103319">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1597 href="https://doi.org/10.1371/journal.ppat.1006141">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1601 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5245903">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727222065">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733320199"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e1614 class=n-a></a>Chen YC, Sheng J, Trang P, <i> et al.</i>: Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections. <i>Viruses.</i> 2018; <b>10</b>(6): pii: E291. <a target=xrefwindow id=d8966e1625 href="http://www.ncbi.nlm.nih.gov/pubmed/29844277">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1628 href="https://doi.org/10.3390/v10060291">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1632 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6024784">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733320199">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732674653"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e1645 class=n-a></a>Jaishankar D, Yakoub AM, Yadavalli T, <i> et al.</i>: An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye. <i>Sci Transl Med.</i> 2018; <b>10</b>(428): pii: eaan5861. <a target=xrefwindow id=d8966e1656 href="http://www.ncbi.nlm.nih.gov/pubmed/29444978">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1659 href="https://doi.org/10.1126/scitranslmed.aan5861">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732674653">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d8966e1672 class=n-a></a>Hill JM, Quenelle DC, Cardin RD, <i> et al.</i>: Inhibition of LSD1 reduces herpesvirus infection, shedding, and recurrence by promoting epigenetic suppression of viral genomes. <i>Sci Transl Med.</i> 2014; <b>6</b>(265): 265ra169. <a target=xrefwindow id=d8966e1683 href="http://www.ncbi.nlm.nih.gov/pubmed/25473037">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1686 href="https://doi.org/10.1126/scitranslmed.3010643">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1690 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4416407">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717973547"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d8966e1700 class=n-a></a>Liang Y, Vogel JL, Arbuckle JH, <i> et al.</i>: Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency. <i>Sci Transl Med.</i> 2013; <b>5</b>(167): 167ra5. <a target=xrefwindow id=d8966e1711 href="http://www.ncbi.nlm.nih.gov/pubmed/23303604">PubMed Abstract </a> | <a target=xrefwindow id=d8966e1714 href="https://doi.org/10.1126/scitranslmed.3005145">Publisher Full Text </a> | <a target=xrefwindow id=d8966e1718 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4778723">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717973547">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 31 Oct 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1726&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1726&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Pediatrics, Microbiology, and Medicine, University of Alabama at Birmingham Children&rsquo;s Hospital, Birmingham, AL, 35233, USA<br/> <sup>2</sup> Department of Pathobiology, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, 70803, USA<br/> <p> <div class=margin-bottom> Richard Whitley <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Joel Baines <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1726/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 31 Oct 2018, 7:1726 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.16157.1">https://doi.org/10.12688/f1000research.16157.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Whitley R and Baines J. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=17644 data-id=16157 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16157.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1726/v1/pdf?article_uuid=9116c98d-399f-494a-b82a-d304c78d140f" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.16157.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Whitley R and Baines J. Clinical management of herpes simplex virus infections: past, present, and future [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1726 (<a href="https://doi.org/10.12688/f1000research.16157.1" target=_blank>https://doi.org/10.12688/f1000research.16157.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=16157 id=mobile-track-article-signin-16157 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16157?target=/articles/7-1726"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17644 /> <input name=articleId type=hidden value=16157 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Thomas M. Kristie</strong>, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health , USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Deepak Shukla</strong>, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, USA; Department of Microbiology and Immunology, University of Illinois at Chicago, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 31 Oct 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1726&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1726&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=40679-39758></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=40677-39757></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1726/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>31 Oct 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Thomas M. Kristie</strong>, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health , USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Deepak Shukla</strong>, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, USA; Department of Microbiology and Immunology, University of Illinois at Chicago, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1726&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1726/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Clinical management of herpes simplex virus...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1726/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1726/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1726/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Whitley R and Baines J');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1726/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1726",
            templates : {
                twitter : "Clinical management of herpes simplex virus infections: past,.... Whitley R and Baines J, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1726/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Clinical management of herpes simplex virus infections: past, present, and future", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Clinical management of herpes simplex virus infections: past, present, and future", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/16157/17644")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "17644");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "39757": 0,
                           "39758": 1,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "a27654c4-0ebe-428c-a06d-23e2cf420bf2";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1726.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1726.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1726.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1726.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1726.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>